Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

The Centers for Medicare & Medicaid Services released details of its proposal to address the expensive costs of Medicare Part B.

President Donald Trump has directed his administration to pursue reclassifying marijuana as a less dangerous drug. The change ...

Chicago-based Amphix Bio has raised $12.5 million in seed funding to advance its experimental paralysis-reversing drug toward ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

The Centers for Medicare & Medicaid Services (CMS) is proposing a groundbreaking drug payment model to address the ...

Chinese biotech innovator Jacobio Pharma has struck a global out-licensing deal with pharmaceutical giant AstraZeneca for a promising cancer drug, marking one of the largest cross-border transactions ...

Special agents and task force officers from the Drug Enforcement Administration’s Louisville Field Division have seized ...

Cricketing great Stuart MacGill will return to court after it was revealed he was fighting his conviction over his role in a ...

Eli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing, doctor outreach and partnerships. Lilly's Mounjaro launched early and is ...